Side-Effect Management

Olanzapine Substitution Effective in Triple Therapy for Carboplatin-Induced CINV

By

Jessica Nye, PhD

Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.

Classifying Patient Reponses to Steroid Therapy for Acute GVHD May Improve Outcomes

By

Jennifer Larson

Researchers identified classifications of acute graft-versus-host-disease to facilitate better management of the adverse effect in patients who undergo hematopoietic cell transplant.

Muscle Health Associated With Symptom Burden, Clinical Outcomes, Survival, in Advanced Cancer

By

Jessica Nye, PhD

In this prospective study, researchers sought to determine the effect of mean muscle mass on clinical outcomes and survival among hospitalized patients with advanced cancer.

Acupuncture Techniques Reduced Chronic Musculoskeletal Pain in Cancer Survivors

By

Jessica Nye, PhD

A randomized trial sought to determine the effectiveness of electroacupuncture and auricular acupuncture in managing musculoskeletal pain in cancer survivors.

Electronic Self-Reporting Tool Improves Symptom Management During Cancer Treatment

By

Vicki Moore, PhD

Results of a phase 3 randomized trial of the eRAPID online system for patients to self-report symptoms while undergoing cancer therapy are presented.

New Guidelines Help Decision Making for the Prevention, Management of Venous Thromboembolism

By

Katie Kosko

The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.

Risk Factors Associated With Chemotherapy-Induced Peripheral Neuropathy

By

Katie Kosko

Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.

Hypertension, Older Age Are Significant Risk Factors for Bleomycin-Induced Lung Injury

By

Katie Kosko

Investigators sought to determine the incidence of BLI on patients with cancer receiving bleomycin-containing regimens.

Laboratory Markers Found to Correlate With Symptom Burden in Relapsed/Refractory Multiple Myeloma

By

Vicki Moore, PhD

Study finds correlation between certain laboratory markers and symptom burden in patients with relapsed/refractory multiple myeloma.

Chronic Immune-Mediated Diarrhea and Colitis Associated With Prolonged Survival in Patients Treated With ICIs

By

Susan Moench, PhD, PA-C

The immune-related AE, immune-mediated diarrhea and colitis, can have a limited course or may exist for long-term periods.